137 related articles for article (PubMed ID: 29312515)
1. Chidamide shows synergistic cytotoxicity with cytarabine via inducing G0/G1 arrest and apoptosis in myelodysplastic syndromes.
Liu Z; Chen J; Wang H; Ding K; Li Y; de Silva A; Sehgal V; Burbano JL; Sundararaj R; Gamage J; Audu V; Fu R
Am J Transl Res; 2017; 9(12):5631-5642. PubMed ID: 29312515
[TBL] [Abstract][Full Text] [Related]
2. A novel histone deacetylase inhibitor Chidamide induces G0/G1 arrest and apoptosis in myelodysplastic syndromes.
Liu Z; Ding K; Li L; Liu H; Wang Y; Liu C; Fu R
Biomed Pharmacother; 2016 Oct; 83():1032-1037. PubMed ID: 27541047
[TBL] [Abstract][Full Text] [Related]
3. Effects of chidamide and its combination with decitabine on proliferation and apoptosis of leukemia cell lines.
Mao J; Li S; Zhao H; Zhu Y; Hong M; Zhu H; Qian S; Li J
Am J Transl Res; 2018; 10(8):2567-2578. PubMed ID: 30210693
[TBL] [Abstract][Full Text] [Related]
4. Chidamide, a novel histone deacetylase inhibitor, inhibits the viability of MDS and AML cells by suppressing JAK2/STAT3 signaling.
Zhao S; Guo J; Zhao Y; Fei C; Zheng Q; Li X; Chang C
Am J Transl Res; 2016; 8(7):3169-78. PubMed ID: 27508038
[TBL] [Abstract][Full Text] [Related]
5. Chidamide, a histone deacetylase inhibitor, induces growth arrest and apoptosis in multiple myeloma cells in a caspase-dependent manner.
Yuan XG; Huang YR; Yu T; Jiang HW; Xu Y; Zhao XY
Oncol Lett; 2019 Jul; 18(1):411-419. PubMed ID: 31289512
[TBL] [Abstract][Full Text] [Related]
6. Chidamide and 5-flurouracil show a synergistic antitumor effect on human colon cancer xenografts in nude mice.
Liu L; Qiu S; Liu Y; Liu Z; Zheng Y; Su X; Chen B; Chen H
Neoplasma; 2016; 63(2):193-200. PubMed ID: 26774139
[TBL] [Abstract][Full Text] [Related]
7. A combination of low-dose decitabine and chidamide resulted in synergistic effects on the proliferation and apoptosis of human myeloid leukemia cell lines.
Xu F; Guo H; Shi M; Liu S; Wei M; Sun K; Chen Y
Am J Transl Res; 2019; 11(12):7644-7655. PubMed ID: 31934307
[TBL] [Abstract][Full Text] [Related]
8. Synergistic effect of HDAC inhibitor Chidamide with Cladribine on cell cycle arrest and apoptosis by targeting HDAC2/c-Myc/RCC1 axis in acute myeloid leukemia.
Gu S; Hou Y; Dovat K; Dovat S; Song C; Ge Z
Exp Hematol Oncol; 2023 Feb; 12(1):23. PubMed ID: 36849955
[TBL] [Abstract][Full Text] [Related]
9. Chidamide in FLT3-ITD positive acute myeloid leukemia and the synergistic effect in combination with cytarabine.
Li X; Yan X; Guo W; Huang X; Huang J; Yu M; Ma Z; Xu Y; Huang S; Li C; Zhou Y; Jin J
Biomed Pharmacother; 2017 Jun; 90():699-704. PubMed ID: 28419965
[TBL] [Abstract][Full Text] [Related]
10. Cooperative effect of chidamide and chemotherapeutic drugs induce apoptosis by DNA damage accumulation and repair defects in acute myeloid leukemia stem and progenitor cells.
Li Y; Wang Y; Zhou Y; Li J; Chen K; Zhang L; Deng M; Deng S; Li P; Xu B
Clin Epigenetics; 2017; 9():83. PubMed ID: 28814980
[TBL] [Abstract][Full Text] [Related]
11. Non-toxic dose chidamide synergistically enhances platinum-induced DNA damage responses and apoptosis in Non-Small-Cell lung cancer cells.
Zhou Y; Pan DS; Shan S; Zhu JZ; Zhang K; Yue XP; Nie LP; Wan J; Lu XP; Zhang W; Ning ZQ
Biomed Pharmacother; 2014 May; 68(4):483-91. PubMed ID: 24721323
[TBL] [Abstract][Full Text] [Related]
12. A novel histone deacetylase inhibitor LT-548-133-1 induces apoptosis by inhibiting HDAC and interfering with microtubule assembly in MCF-7 cells.
Xue J; Wu G; Ejaz U; Akhtar F; Wan X; Zhu Y; Geng A; Chen Y; He S
Invest New Drugs; 2021 Oct; 39(5):1222-1231. PubMed ID: 33788074
[TBL] [Abstract][Full Text] [Related]
13. Chidamide, a histone deacetylase inhibitor, functions as a tumor inhibitor by modulating the ratio of Bax/Bcl-2 and P21 in pancreatic cancer.
Zhao B; He T
Oncol Rep; 2015 Jan; 33(1):304-10. PubMed ID: 25384499
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase inhibitor chidamide induces growth inhibition and apoptosis in NK/T lymphoma cells through ATM-Chk2-p53-p21 signalling pathway.
Zhou J; Zhang C; Sui X; Cao S; Tang F; Sun S; Wang S; Chen B
Invest New Drugs; 2018 Aug; 36(4):571-580. PubMed ID: 29504068
[TBL] [Abstract][Full Text] [Related]
15. Chidamide and decitabine can synergistically induce apoptosis of Hodgkin lymphoma cells by up-regulating the expression of PU.1 and KLF4.
Jiang T; Wang F; Hu L; Cheng X; Zheng Y; Liu T; Jia Y
Oncotarget; 2017 Sep; 8(44):77586-77594. PubMed ID: 29100410
[TBL] [Abstract][Full Text] [Related]
16. [Inducing effect of chidamide on apoptosis of multiple myeloma cells and its relerance to DNA damage response].
Xu L; Tang HL; Gong X; Xin XL; Dong Y; Gao GX; Shu MM; Chen XQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Apr; 23(2):450-4. PubMed ID: 25948203
[TBL] [Abstract][Full Text] [Related]
17. Chidamide Combined With Doxorubicin Induced p53-Driven Cell Cycle Arrest and Cell Apoptosis Reverse Multidrug Resistance of Breast Cancer.
Cao L; Zhao S; Yang Q; Shi Z; Liu J; Pan T; Zhou D; Zhang J
Front Oncol; 2021; 11():614458. PubMed ID: 33738256
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of chidamide on the growth of human adenoid cystic carcinoma cells.
Yang S; Nan P; Li C; Lin F; Li H; Wang T; Zhou C; Zhang X; Meng X; Qian H; Wang H; Dong M
Biomed Pharmacother; 2018 Mar; 99():608-614. PubMed ID: 29710459
[TBL] [Abstract][Full Text] [Related]
19. Preclinical Evaluation of the HDAC Inhibitor Chidamide in Transformed Follicular Lymphoma.
Zhong M; Tan J; Pan G; Jiang Y; Zhou H; Lai Q; Chen Q; Fan L; Deng M; Xu B; Zha J
Front Oncol; 2021; 11():780118. PubMed ID: 34926293
[TBL] [Abstract][Full Text] [Related]
20. Chidamide works synergistically with Dasatinib by inducing cell-cycle arrest and apoptosis in acute myeloid leukemia cells.
Deng M; Xiao H; Peng H; Yuan H; Xiao X; Liu S
Mol Cell Biochem; 2023 Apr; 478(4):851-860. PubMed ID: 36107284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
